POSSIBILITIES FOR THE PREVENTION OF POSTCOITAL CYSTITIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Chronic postcoital cystitis is considered as a type of chronic cystitis. The European Association of Urology and the Russian Society of Urology recommend to prescribe antibiotics if behavioral therapy and non-antimicrobial prophylaxis are ineffective. For the prevention of recurrences of postcoital cystitis, it is recommended to use combinations of substances that have an immunoprotective effect, improve the trophism of the bladder mucosa and have an antimicrobial effect. The dietary supplement Uronext contains D-mannose 2000 mg, proanthocyanidins 36 mg (or 500 mg of branded Cran-Max cranberry extract concentrate) and vitamin D3 1 mcg. Considering their properties and the results of previous studies, we carry out our own trial. Aim. To evaluate the efficiency of the biological additive Uronext for the prevention of recurrent postcoital cystitis in women in parallel-group study. Materials and methods. A total of 86 women were randomized into 2 groups of 43 patients (group 1, interventional and group 2, control). In the group 1 patients received Uronext one sachet once after each sexual intercourse, while in the group 2 women did not receive prophylactic treatment. The follow-up period was 180 days. Results. During the follow-up, we noted that Uronext reduced the frequency of relapses of postcoital cystitis by 3 times. The dietary supplement was well tolerated by patients. Conclusions. Based on our data, we can conclude that the use ofUronext according to the scheme of one sachet once after sexual intercourse for 6 months allows to effectively influence pathogenesis of postcoital cystitis, reduce the frequency of recurrences, thereby significantly improving the quality of life of patients.

Full Text

Restricted Access

About the authors

A. I Neymark

FGBOU VO "Altai State Medical University" of the Ministry of Health of Russia

Email: urologagmu@mail.ru
Ph.D., MD, professor, Head of the Department of Urology and Andrology with a course of Specialized Surgery Barnaul, Russia

B. A Neymark

FGBOU VO "Altai State Medical University" of the Ministry of Health of Russia

Email: urologagmu@mail.ru
Ph.D., MD, professor at the Department of Urology and Andrology with a course of Specialized Surgery Barnaul, Russia

N. A Nozdrachev

FGBOU VO "Altai State Medical University" of the Ministry of Health of Russia

Email: nozdrachevuro@mail.ru
Ph.D., associate professor at the Department of Urology and Andrology with a course of Specialized Surgery Barnaul, Russia

Yu. S Kovaleva

FGBOU VO "Altai State Medical University" of the Ministry of Health of Russia

Email: julia_isk@mail.ru
Ph.D., MD, associate professor, Head of the Department of Dermatology and Venerology, Cosmetology and Immunology Barnaul, Russia

M. V Razdorskaya

NUZ KB “RJD-Medicine”

Email: mvrazdorskaya@mail.ru
Ph.D., MD, urologist Barnaul, Russia

M. A Mel'nik

FGBOU VO "Altai State Medical University" of the Ministry of Health of Russia

Email: urologagmu@mail.ru
Ph.D., assistant, associate professor at the Department of Urology and Andrology with a course of Specialized Surgery Barnaul, Russia

References

  1. Loran O.B. Chronic cystitis in women. Doctor 1996;(8):6-9.Russian (Лоран О.Б. Хронический цистит у женщин. Врач 1996;(8):6-9).
  2. Урология. Российские клинические рекомендации [под ред. Ю.Г. Аляева, П.В. Глыбочко, Д.Ю. Пушкаря]. М.: Гэотар-Медиа, 2015.
  3. Oteo J., Bautista V., Lara N., Cuevas O., Arroyo M., Fernandez S., et al. Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. J AntimicrobChemother. 2010;65(11):2459-2463. doi: 10.1093/jac/dkq346.
  4. Перепанова Т.С., Козлов Р.С., Руднов В.А. и др. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М.; 2020.
  5. Bonkat G., Bartoletti R., Bruyere F. et al. EAU Guideline of Urological Infections. European Association of Urology; 2021 (Elecrtonic resource.) URL: http://uroweb.org/guideline/urological-infections. (access date: 06.04.2021).
  6. Рылова Н.В., Мальцев С.В., Жолинский А.В. Роль витамина D в регуляции иммунной системы. Практическая медицина. 2019;17(2):10-14.
  7. Nseir W., Taha M., Nemarny H., Mograbi J. The association between serum levels of Vitamin D and recurrent urinary tract infections in premenopausal women.Int J Infect Dis. 2013;17: e1121-1124. doi: 10.1016/j.ijid.2013.06.007
  8. Van der Starre W.E., van Nieuwkoop C., Thomson U. et al. Urinary proteins, Vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: A case control study. PLoS One. 2015;10: e0121302. doi: 10.1371/journal.pone.0121302.
  9. Hertting O., Holm Â., Lüthje P. et al. Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One. 2010;5: e15580. doi: 10.1371/journal.pone.0015580.
  10. Perret J.L., Lodge C.J. Seasonality and total 25-hydroxyvitamin D levels as sources of potential misclassification of Vitamin D deficiency. Ann Am Thorac Soc. 2014;11:1336-1337. doi: 10.1513/AnnalsATS.201406-282LE
  11. Porru D., Parmigiani A., Tinelli C. et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. J Clin Urol. 2014;7(3):208-213. doi: 10.1177/2051415813518332.
  12. Кузьменко А.В., Кузьменко В.В., Гяургиев Т.А. Эффективность применения комбинированной антибактериально-пребиотической терапии в сочетании с D-маннозой у женщин с неосложненной инфекцией нижних мочевыводящих путей. Урология. 2019;(6):38-43. doi: 10.18565/urology.2019.6.38-43.
  13. Кузьмин И.В., Слесаревская М.Н., Аль-Шукри С.Х. Антиа.дгезивная стратегия неантибактериальной профилактики рецидивирующей инфекции нижних мочевыводящих путей. Урология. 2021;(3):5-12). doi: 10.18565/urology.2021.3.5-12.
  14. Gouin S.G., Wellens A., Bouckaert J., Kovensky J. Synthetic multimericheptylmannosides as potent antiadhesives of uropathogenic Escherichia coli. Chem Med Chem. 2009;4:749-755. Doi: 10.1002/ cmdc.200900034.
  15. Kranjcec B., Papes D., Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32:79-84. doi: 10.1007/s00345-013-1091-6.
  16. Howell A.B. Cranberry proanthocyanidins and the maintenance of urinary tract health. Crit Rev Food Sci Nutr. 2002;42(Suppl. 3):273-278. doi: 10.1080/10408390209351915
  17. Ahuja S., Kaack B., Roberts J. Loss of fimbrial adhesion with the addition of Vacciniummacrocarpon to the growth medium of P-fimbriated Escherichia coli. J Urol. 1988;159(2):559-562. doi: 10.1016/S0022-5347 (01) 63983-1
  18. Youdim K.A., Mcdonnald J., Kalt W., Joseph J.A. Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J Nutr Biochem. 2002;13(5):282-288. doi: 10.1016/S0955-2863 (01) 00221-2.
  19. Kowalczyk E., Krzesinski P., Kura M. et al. Anthocyanins in medicine Pol J Pharmacol. 2003;55:699-702. doi: 10.1016/S0169-409X (03) 00075-9.
  20. Bohbot J.-M. Results of a randomised, double-blind study on the prevention of recurrent cystitis with GynDelta®. The Gynaecologist’s and Obstetrician’s Journal. Special issue from the C.C.D. Laboratory. 2007.
  21. Гланц С. Медико-биологическая статистика. Пер. с англ. М., Практика, 1998. 459 с.
  22. Аль-Шукри С.Х., Кузьмин И.В., Слесаревская М.Н., и др. Применение русскоязычной версии шкалы симптомов тазовой боли, ургентности и частоты мочеиспускания (PUF Scale) у больных с синдромом болезненного мочевого пузыря. Урологические ведомости. 2017;7(2):5-9). doi: 10.17816/uroved725-9.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2022 Bionika Media